Showing results (21-30 of 107) with videos related to
Sort By:
Pageof 11
Cancer Research Communications|June 28, 2023
NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid TumorsMichael Cecchini, Zenta Walther, Wei Wei, et al.Pediatric Blood & Cancer|September 11, 2019
Cediranib phase-II study in children with metastatic alveolar soft-part sarcoma (ASPS)Julia W Cohen, Brigitte C Widemann, Joanne Derdak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patientsJean L Grem, Nancy Harold, Bruce Keith, et al.Cancer Biology & Therapy|October 14, 2009
Immunohistochemical detection of poly(ADP-ribose) polymerase inhibition by ABT-888 in patients with refractory solid tumors and lymphomasSherry X Yang, Shivaani Kummar, Seth M Steinberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2011
Phase I pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumorsIgor Puzanov, Wooin Lee, Alice P Chen, et al.Neuro-Oncology Advances|September 17, 2020
The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromasSadhana Jackson, Eva H Baker, Andrea M Gross, et al.Investigational New Drugs|March 22, 2016
Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancerShivaani Kummar, James L Wade, Amit M Oza, et al.Molecular Cancer Therapeutics|February 4, 2021
Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical BiopsiesWilliam G Herrick, Casey L Kilpatrick, Melinda G Hollingshead, et al.Journal of Oncology Practice|October 5, 2018
What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials?Katherine V Ferry-Galow, Vivekananda Datta, Hala R Makhlouf, et al.Cancer Informatics|April 11, 2015
GeneMed: An Informatics Hub for the Coordination of Next-Generation Sequencing Studies that Support Precision Oncology Clinical TrialsYingdong Zhao, Eric C Polley, Ming-Chung Li, et al.Pageof 11